James Oliviero
Algemeen Directeur bij CHECKPOINT THERAPEUTICS, INC.
Vermogen: 666 488 $ op 30-04-2024
Profiel
James F.
Oliviero is currently the President, Chief Executive Officer & Director at Checkpoint Therapeutics, Inc. He is also an Independent Director at Nuvectis Pharma, Inc. Previously, he served as the Finance Director at ACCESS Oncology, Inc. from 1999 to 2003.
He then worked as the Chief Financial Officer & Treasurer at Keryx Biopharmaceuticals, Inc. from 2003 to 2015.
Mr. Oliviero completed his undergraduate degree at Goizueta Business School-Emory.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-03-2024 | 341 780 ( 0.98% ) | 485 328 $ | 30-04-2024 | |
NUVECTIS PHARMA, INC.
0.16% | 16-06-2023 | 27 828 ( 0.16% ) | 181 160 $ | 30-04-2024 |
Actieve functies van James Oliviero
| Bedrijven | Functie | Begin |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Algemeen Directeur | 13-10-2015 |
| NUVECTIS PHARMA, INC. | Directeur/Bestuurslid | 01-07-2021 |
Eerdere bekende functies van James Oliviero
| Bedrijven | Functie | Einde |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Financieel Directeur/CFO | 01-09-2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a private company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Financieel Directeur/CFO | 01-05-2003 |
Opleiding van James Oliviero
| Goizueta Business School-Emory | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Health Technology |
| NUVECTIS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a private company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
